Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

NCT05852717

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

NCT06746155

Conditions
Depressive Disorder, Depressive Disorder, Major, Disease Attributes, +6 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • Nova Scotia Health Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

NCT06007937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering West Harrison (All Protocol Activities) Harrison, New York, United States
View Trial Details
Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT07104032

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • HonorHealth Cancer Center Scottsdale, Arizona, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC Irvine Health Orange, California, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

NCT05714839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site Bullhead City, Arizona, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
View all 36 locations
View Trial Details
Recruiting

CAR-T Cell Therapy for ALL

NCT07695012

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • National University of Medical Sciences, Clinical Trial Unit Rawalpindi, Pakistan
View Trial Details
Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

NCT03460977

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +23 more
Locations
  • Banner-University Medical Center Tucson Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Arizona Urology Specialists, PLLC Tucson, Arizona, United States
View all 83 locations
View Trial Details

Related conditions